The stock's fall snapped a four-day winning streak.

Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of ...

Rodger Currie will join Bristol Myers Squibb next month as senior vice president of U.S. policy and government affairs.

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

This was the stock's fourth consecutive day of gains.

BMSCH opens a Same Day Services center for kids needing infusion therapies, backed by a $2.5M gift from the Bristol Myers ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic ...

At current levels, we believe AMGN scores above BMY, buoyed by solid fundamentals and recent positive estimate revisions.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology ...

The manufacturer's parent firm recently told investors it's grappling with $100 million in anticipated costs from tariffs.